Anti-Human ITGB2 Therapeutic Antibody (Rovelizumab)

Recombinant monoclonal antibody to CD18. Rovelizumab, also known as LeukArrest and Hu23F2G, is a humanized monoclonal antibody which was an experimental immunosuppressive drug. The drug is a monoclonal antibody that suppresses white blood cells which become overly active during shock.
Supplier Creative Biolabs
Product # TAB-044
Pricing Inquiry
Host Mouse
Target ITGB2
Species Reactivity Human
Type IgG4
Applications Suitable for use in Neut, ELISA, IF, IP, FuncS, FC, IHC and most other immunological methods.
Storage 4°C. For long term storage, aliquot and store at -20°C. Repeated thawing and freezing must be avoided.
Feedback